A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer
Trial details
- Registry ID
- NCT07464145
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder CancerNCT07464145 | RLMD | Phase 3 | Not yet recruiting | 2029-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |